Neurosurgery Department, CHU Liège, Liège, Belgium.
Acta Neurol Belg. 2020 Aug;120(4):867-871. doi: 10.1007/s13760-018-01065-4. Epub 2019 Jan 30.
Spinal cord stimulation (SCS) is the most frequently used neuromodulation technique even for neurogenic pain from a peripheral nerve injury although peripheral nerve stimulation (PNS) has been designed for this purpose. PNS appears less invasive than SCS or deep brain stimulation. It provides greater and specific target coverage and it could be more cost-effective than SCS because low electrical stimulation is exclusively delivered to the precise painful territory. We report a case of excellent result following median nerve stimulation at arm level after SCS failure and a 10-year history of intense pain. PNS would certainly have been considered much earlier if it was accepted and reimbursed by the Belgium National Insurance. PNS is a safe, simple, and efficient technique available for decades but it is still considered as experimental and underemployed. Belgian National Insurance fears an explosion of indications on neuromodulation if PNS was reimbursed. We consider that PNS aside SCS and other neuromodulation techniques should be made available in Belgium in case of peripheral chronic neuropathic pain.
脊髓刺激(SCS)是最常用的神经调节技术,即使对于外周神经损伤引起的神经性疼痛也是如此,尽管外周神经刺激(PNS)是为此目的而设计的。与 SCS 或深部脑刺激相比,PNS 的侵入性更小。它提供了更大和更具体的目标覆盖范围,并且可能比 SCS 更具成本效益,因为仅将低强度的电刺激传递到精确的疼痛区域。我们报告了一例 SCS 治疗失败后在手臂水平进行正中神经刺激的极佳结果,该患者的剧烈疼痛已有 10 年历史。如果比利时国家保险接受并报销 PNS,那么它肯定会更早被考虑。PNS 是一种安全、简单、有效的技术,已经使用了几十年,但它仍被认为是实验性的,并且应用不足。比利时国家保险担心如果 PNS 得到报销,神经调节的适应症会激增。我们认为,如果比利时出现外周慢性神经性疼痛,除了 SCS 和其他神经调节技术外,还应提供 PNS。